Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-22,646
Closed -$1.2M 393
2018
Q2
$1.2M Sell
22,646
-6,536
-22% -$348K 0.27% 211
2018
Q1
$1.46M Sell
29,182
-332
-1% -$16.7K 0.36% 144
2017
Q4
$1.42M Sell
29,514
-16,148
-35% -$765K 0.35% 151
2017
Q3
$2.1M Sell
45,662
-45,482
-50% -$1.97M 0.4% 125
2017
Q2
$4.03M Buy
+91,144
New +$3.83M 0.68% 61
2017
Q1
Sell
-117,609
Closed -$4.83M 198
2016
Q4
$4.83M Buy
+117,609
New +$4.33M 1.15% 39

Other funds holding SNV

361 Capital's SNV Position: Q3 2018 in Review

361 Capital sold out of Synovus (SNV) in Q3 2018, closing a stake of 22,646 shares — an estimated $1.2M sold.

361 Capital first reported a position in SNV in Q4 2016 and held it in 6 quarters. The position peaked at $4.83M in Q4 2016. 336 funds tracked by Wall St. Rank hold SNV as of Q3 2018.

  • 361 Capital reported no remaining Synovus position as of Q3 2018 after selling out during the quarter.
  • 361 Capital sold 22,646 Synovus shares in Q3 2018, an estimated $1.2M.
  • 361 Capital first reported a position in Synovus in Q4 2016 and held it in 6 quarters.
  • 361 Capital's Synovus position peaked at $4.83M in Q4 2016.
  • 336 funds tracked by Wall St. Rank held Synovus as of Q3 2018.

Based on 361 Capital's 13F filing for Q3 2018, filed 13 Nov 2018.